Cannabinoids and pain

Psychiatric Times

Volumn 25, Issue 2, 2008, Pages 79-

  King, Steven A ^a,b  

^a New York University School of Medicine ^*

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40849136340     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Slatkin N. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. J Support Oncol. 2007;5(suppl 13):1-9.
2. Skrabek RQ, Galimova L. A randomized double-blind placebo controlled trial assessing the effect of the oral cannabinoid nabilone for pain and quality of life in patients with fibromyalgia. Presented at: the Annual Meeting of the American Pain Society; May 5-7, 2007; Washington, DC.
3. Comeau P. New dosage limits for medical marijuana: but Where's the science? CMAJ. 2007;177:556-557.
4. Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68:515-521.
5. Walker JM, Huang S. Cannabinoid analgesia. Pharmacol Ther. 2002;95:127-135.
6. Agarwal N, Pacher P, Tegeder I, et al. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci. 2007;10:870-879.
7. Trang T, Sutak M, Jhamandas K. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance. Neuroscience. 2007;146:1275-1288.